These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29240867)
1. Management of Late-Onset, Recurrent Facial Nodular Reaction After Poly-L-Lactic (PLLA) Injections. O'Daniel G J Drugs Dermatol; 2017 Dec; 16(12):1297-1299. PubMed ID: 29240867 [TBL] [Abstract][Full Text] [Related]
2. High-Frequency Ultrasound for Long-term Safety Assessment of Poly-L-Lactic Acid Facial Filler. Li A; Long A; Fang R; Mao X; Sun Q Dermatol Surg; 2022 Oct; 48(10):1071-1075. PubMed ID: 35834659 [TBL] [Abstract][Full Text] [Related]
3. Understanding, avoiding, and treating potential adverse events following the use of injectable poly-L-lactic acid for facial and nonfacial volumization. Vleggaar D; Fitzgerald R; Lorenc ZP J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s35-9. PubMed ID: 24719076 [TBL] [Abstract][Full Text] [Related]
4. Filler migration to the forehead due to multiple filler injections in a patient addicted to cosmetic fillers. Lin CH; Chiang CP; Wu BY; Gao HW J Cosmet Laser Ther; 2017 Apr; 19(2):124-126. PubMed ID: 27813656 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of filler adverse effects: an algorithm. Feller-Heppt G; Haneke E; Heppt MV Facial Plast Surg; 2014 Dec; 30(6):647-55. PubMed ID: 25536132 [TBL] [Abstract][Full Text] [Related]
12. Biostimulatory effects of polydioxanone, poly-d, l lactic acid, and polycaprolactone fillers in mouse model. Kwon TR; Han SW; Yeo IK; Kim JH; Kim JM; Hong JY; Lee BC; Lee SE; Moon HS; Kwon HJ; Kim BJ J Cosmet Dermatol; 2019 Aug; 18(4):1002-1008. PubMed ID: 30985064 [TBL] [Abstract][Full Text] [Related]
13. Practices in the Usage and Reconstitution of Poly-L-Lactic Acid. Lin MJ; Dubin DP; Goldberg DJ; Khorasani H J Drugs Dermatol; 2019 Sep; 18(9):880-886. PubMed ID: 31524343 [TBL] [Abstract][Full Text] [Related]
14. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies. Skrzypek E; Górnicka B; Skrzypek DM; Krzysztof MR J Cosmet Laser Ther; 2019; 21(2):65-68. PubMed ID: 29757038 [TBL] [Abstract][Full Text] [Related]
15. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology. Vleggaar D; Fitzgerald R; Lorenc ZP J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075 [TBL] [Abstract][Full Text] [Related]
16. Adverse effects of fillers and their histopathology. Haneke E Facial Plast Surg; 2014 Dec; 30(6):599-614. PubMed ID: 25536126 [TBL] [Abstract][Full Text] [Related]
17. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up. Alijotas-Reig J; Garcia-Gimenez V; Vilardell-Tarres M Dermatology; 2009; 219(4):303-8. PubMed ID: 19797889 [TBL] [Abstract][Full Text] [Related]
19. Poly-L-lactic acid for the Improvement of photodamage and rhytids of the décolletage. Wilkerson EC; Goldberg DJ J Cosmet Dermatol; 2018 Aug; 17(4):606-610. PubMed ID: 29119683 [TBL] [Abstract][Full Text] [Related]
20. Self-injection of dermal filler: an underdiagnosed entity? Raoof N; Salvi SM Br J Dermatol; 2015 Mar; 172(3):782-3. PubMed ID: 25109339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]